U.S. GoldMining Inc. Audit Committee Chair Resigns; Nasdaq Grants Cure Period

What Happened
U.S. GoldMining Inc. (filed Form 8-K, Item 3.01) announced that Aleksandra Bukacheva resigned from the Board and as Chair of the Audit Committee, effective August 14, 2026. The Company received notice from Nasdaq on August 27, 2026 that Bukacheva’s departure caused noncompliance with Nasdaq Listing Rule 5605 (audit committee composition). The Company said the resignation was not due to any disagreement with the Company’s operations, policies or practices.

Key Details

• Resignation: Aleksandra Bukacheva notified the Company on August 11, 2026; resignation effective August 14, 2026.
• Nasdaq notice received: August 27, 2026, citing noncompliance with Nasdaq Listing Rule 5605(c) (audit committee rules).
• Cure period: Nasdaq will allow the Company to regain compliance by the earlier of its next annual shareholders’ meeting or August 14, 2027; if the next annual meeting is before February 10, 2027, compliance must be shown by February 10, 2027.
• Requirement: Nasdaq Listing Rule 5605(c)(2) requires the Audit Committee to have at least three independent directors who meet heightened independence standards; the Board is searching for a qualified independent director to restore compliance.

Why It Matters
For investors, the key point is that U.S. GoldMining is currently noncompliant with Nasdaq’s audit committee membership rules but has been granted a cure period and has not been delisted. The Company is actively searching for an independent director to re-establish a three-member audit committee; failure to timely cure could lead to further Nasdaq action. The filing also notes the resignation was not due to any disagreement with company practices, which limits immediate governance concerns but remains a material corporate governance development.